Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blue Light Therapy for C. Acnes Bioburden
NCT04300010Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by University of Wisconsin–Madison. Primary endpoints: Number of Participants With C. Acnes Bacterium Culture After Treatment at 2 days, Median Colony Forming Units (CFU) After Treatment at 2 days and 2 more. Started Oct 2020; status: completed.
Beyond the preview
Go deeper on NCT04300010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04300010.